Saturday, 29 February 2020

Want to Receive News & Updates from AHDB?

Stay up to date on the latest information you need to devise benefit designs, make coverage decisions, and further value-based healthcare! Sign up for our newsletter or print publications today by entering your contact information below and clicking "Subscribe".

First Name *

Last Name *

Email Address *

Email Address (Verify) *

AHDB Print Edition

We will request your mailing address on the next page.

AHDB E-Newsletters & Communications

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.

Home
Issues
2020
February 2020 Vol 13, No 1
2019
December 2019 Vol 12, no 8
November 2019 Vol 12, no 7
October 2019 Vol 12, No 6
September 2019 Vol 12, No 5
June/July 2019 Vol 12, No 4
May 2019 Vol 12, No 3
April 2019 - Vol 12 No 2
February 2019 - Vol 12 No 1
2018
December 2018 Vol 11, No 9
November 2018 Vol 11, No 8
October 2018 Vol 11 No 7
September 2018 Vol 11, No 6
July 2018 - Vol 11 No 5
June 2018 - Vol 11 No 4
May 2018 - Vol 11 No 3
April 2018 - Vol 11 No 2
February 2018 - Vol 11 No 1
Issue Archive
Value-Based Care in Cardiometabolic Health
Special Issues
Supplements
2020 Special Issues
February 2020 Vol 13, Special Issue
2019 Special Issues
August 2019, Vol 12, Special Issue: Payers’ Perspectives In Oncology: ASCO 2019 Highlights
2019 Payers' Guide Mid-Year Addendum
March 2019 Vol 12, Tenth Annual Payers' Guide
January/February 2019, Vol 12, Special Issue: Payers’ Perspectives in Oncology: ASH 2018 Highlights
February 2019 - Vol 12 No 1 Supplement 1: Budget Impact of Omadacycline for the Treatment of Patients with Community-Acquired Bacterial Pneumonia in the United States from the Hospital Perspective
February 2019 - Vol 12 No 1 Supplement 2: Budget Impact Model of Omadacycline on Replacing a Proportion of Existing Treatment Options Among Patients Who Present to the Emergency Department with Acute Bacterial Skin and Skin Structure Infections
Special Issue Archive
For Authors
Call for Papers
Submit a Manuscript
Instructions for Authors
Join Peer Review
Permissions
Topics
Web Exclusives
All Web Exclusives
Web Exclusive Topics
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Conference Correspondent
ASH 2019 - Chronic Lymphocytic Leukemia
ASCO 2019 - Chronic Lymphocytic Leukemia
ASH 2018 - CLL
ID Week 2018
ASH 2017 - CLL
ACR 2017 - Rheumatoid Arthritis
ASCO 2017 - Chronic Lymphocytic Leukemia
ASCO 2017 - Acute Myeloid Leukemia
ASH 2016 - Multiple Myeloma
ASH 2016 - Chronic Lymphocytic Leukemia
About
About AHDB
About Engage HC
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Glossary

Laurence Gozalo, PhD

Economist
Groupe d’analyse Ltée, Montréal
Québec, Canada

Economist
Groupe d’analyse Ltée, Montréal
Québec, Canada

Authored Items

Treatment Sequences and Pharmacy Costs of 2 New Therapies for Metastatic Castration-Resistant Prostate Cancer

Lorie A. Ellis, PhD, Laurence Gozalo, PhD, Marie-Hélène Lafeuille, MA, Patrick Lefebvre, MA, Scott McKenzie, MD, Dominic Pilon, MA, Matthew Mitchell, PharmD, MBA, FAMCP

June 2015, Vol 8, No 4 in Business

Last modified: June 23, 2015

Home
About
Contact Us
Terms of Use
Privacy Policy
Advertising Policy

Copyright © 2019 Engage Healthcare Communications, LLC. All rights reserved.